Fragile X Syndrome: The GABAergic System and Circuit Dysfunction

被引:135
作者
Paluszkiewicz, Scott M. [1 ,2 ]
Martin, Brandon S. [1 ,2 ]
Huntsman, Molly M. [1 ]
机构
[1] Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA
[2] Georgetown Univ Med Ctr, Interdisciplinary Program Neurosci, Washington, DC USA
关键词
Inhibition; Fragile X mental retardation protein; Synapse; Developmental disorder; Autism spectrum disorders; Cerebral cortex; Amygdala; MENTAL-RETARDATION PROTEIN; GABA(A) RECEPTOR SUBUNIT; FMR1 KNOCKOUT MICE; HIPPOCAMPAL PYRAMIDAL CELLS; RAT BASOLATERAL AMYGDALA; SHORT-TERM TREATMENT; BARREL FIELD CORTEX; FAST-SPIKING CELLS; MOUSE MODEL; INHIBITORY CIRCUITS;
D O I
10.1159/000329420
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fragile X syndrome (FXS) is a neurodevelopmental disorder characterized by intellectual disability, sensory hypersensitivity, and high incidences of autism spectrum disorders and epilepsy. These phenotypes are suggestive of defects in neural circuit development and imbalances in excitatory glutamatergic and inhibitory GABAergic neurotransmission. While alterations in excitatory synapse function and plasticity are well-established in Fmr1 knockout (KO) mouse models of FXS, a number of recent electrophysiological and molecular studies now identify prominent defects in inhibitory GABAergic transmission in behaviorally relevant forebrain regions such as the amygdala, cortex, and hippocampus. In this review, we summarize evidence for GABAergic system dysfunction in FXS patients and Fmr1 KO mouse models alike. We then discuss some of the known developmental roles of GABAergic signaling, as well as the development and refinement of GABAergic synapses as a framework for understanding potential causes of mature circuit dysfunction. Finally, we highlight the GABAergic system as a relevant target for the treatment of FXS. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:349 / 364
页数:16
相关论文
共 190 条
[1]   NUCLEUS BASALIS MAGNOCELLULARIS AND HIPPOCAMPUS ARE THE MAJOR SITES OF FMR-1 EXPRESSION IN THE HUMAN FETAL BRAIN [J].
ABITBOL, M ;
MENINI, C ;
DELEZOIDE, AL ;
RHYNER, T ;
VEKEMANS, M ;
MALLET, J .
NATURE GENETICS, 1993, 4 (02) :147-153
[2]   Early developmental alterations in GABAergic protein expression in fragile X knockout mice [J].
Adusei, Daniel C. ;
Pacey, Laura K. K. ;
Chen, Duke ;
Hampson, David R. .
NEUROPHARMACOLOGY, 2010, 59 (03) :167-171
[3]   Expression of FMR1, FXR1, and FXR2 genes in human prenatal tissues [J].
Agulhon, C ;
Blanchet, P ;
Kobetz, A ;
Marchant, D ;
Faucon, N ;
Sarda, P ;
Moraine, C ;
Sittler, A ;
Biancalana, V ;
Malafosse, A ;
Abitbol, M .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (08) :867-880
[4]   Refining the roles of GABAergic signaling during neural circuit formation [J].
Akerman, Colin J. ;
Cline, Hollis T. .
TRENDS IN NEUROSCIENCES, 2007, 30 (08) :382-389
[5]   Depolarizing GABAergic conductances regulate the balance of excitation to inhibition in the developing retinotectal circuit in vivo [J].
Akerman, Colin J. ;
Cline, Hollis T. .
JOURNAL OF NEUROSCIENCE, 2006, 26 (19) :5117-5130
[6]   Modulation of neocortical interneurons: extrinsic influences and exercises in self-control [J].
Bacci, A ;
Huguenard, JR ;
Prince, DA .
TRENDS IN NEUROSCIENCES, 2005, 28 (11) :602-610
[7]   From mRNP trafficking to spine dysmorphogenesis: The roots of fragile X syndrome [J].
Bagni, C ;
Greenough, WT .
NATURE REVIEWS NEUROSCIENCE, 2005, 6 (05) :376-387
[8]   Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse [J].
Bakker, CE ;
Otero, YD ;
Bontekoe, C ;
Raghoe, P ;
Luteijn, T ;
Hoogeveen, AT ;
Oostra, BA ;
Willemsen, R .
EXPERIMENTAL CELL RESEARCH, 2000, 258 (01) :162-170
[9]   Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function [J].
Bassell, Gary J. ;
Warren, Stephen T. .
NEURON, 2008, 60 (02) :201-214
[10]   THE DEVELOPMENTAL INTEGRATION OF CORTICAL INTERNEURONS INTO A FUNCTIONAL NETWORK [J].
Batista-Brito, Renata ;
Fishell, Gord .
DEVELOPMENT OF NEURAL CIRCUITRY, 2009, 87 :81-+